amphetamine sulfate

Generic: amphetamine sulfate

Labeler: aurolife pharma, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name amphetamine sulfate
Generic Name amphetamine sulfate
Labeler aurolife pharma, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

amphetamine sulfate 5 mg/1

Manufacturer
Aurolife Pharma, LLC

Identifiers & Regulatory

Product NDC 13107-259
Product ID 13107-259_992a765b-f8cb-4311-b25a-053c11a90bab
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211639
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2019-01-31

Pharmacologic Class

Classes
central nervous system stimulant [epc] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13107259
Hyphenated Format 13107-259

Supplemental Identifiers

RxCUI
884655 1600695
UNII
6DPV8NK46S

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amphetamine sulfate (source: ndc)
Generic Name amphetamine sulfate (source: ndc)
Application Number ANDA211639 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (13107-259-01)
source: ndc

Packages (1)

13107-259-01 100 TABLET in 1 BOTTLE (13107-259-01)

Ingredients (1)

amphetamine sulfate (5 mg/1)

Linked Drug Pages (1)

Amphetamine Sulfate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "992a765b-f8cb-4311-b25a-053c11a90bab", "openfda": {"unii": ["6DPV8NK46S"], "rxcui": ["884655", "1600695"], "spl_set_id": ["20735c2e-6304-425f-a4e4-584f6f90d6a0"], "manufacturer_name": ["Aurolife Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13107-259-01)", "package_ndc": "13107-259-01", "marketing_start_date": "20190131"}], "brand_name": "Amphetamine Sulfate", "product_id": "13107-259_992a765b-f8cb-4311-b25a-053c11a90bab", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "13107-259", "dea_schedule": "CII", "generic_name": "Amphetamine Sulfate", "labeler_name": "Aurolife Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE SULFATE", "strength": "5 mg/1"}], "application_number": "ANDA211639", "marketing_category": "ANDA", "marketing_start_date": "20190131", "listing_expiration_date": "20261231"}